Radiobiologically based assessments of the net costs of fractionated focal radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 5, 1998, Pages 1139-1148

  Jones, Bleddyn ^a   Dale, Roger G ^b  

^a CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Focal radiotherapy; Fractionation; Linear Quadratic Model, Health economics; Radiobiology

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; DOSIMETRY; HEALTH ECONOMICS; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOBIOLOGY; RADIOSENSITIVITY; SYSTEM ANALYSIS; TREATMENT FAILURE; TREATMENT PLANNING;

CELL DIVISION; COSTS AND COST ANALYSIS; DOSE FRACTIONATION; HUMANS; LINEAR MODELS; MODELS, ECONOMETRIC; NEOPLASMS; RADIOBIOLOGY; RADIOTHERAPY; TREATMENT FAILURE;

EID: 0032527654     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00155-2     Document Type: Article

References (25)

1. Horiot J.-C., Bontemps P., van den Bogaert, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers Results of the EORTC 22851 Randomised trial . Radiother. Oncol. 44:1997;111-121.
2. Dische S., Saunders M., Barrett A., et al. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother. Oncol. 44:1997;123-126.
3. Vijayakumar S., Chen G.T. Implementation of three dimensional conformal radiation therapy Prospects, opportunities, and challenges . Int. J. Radiat. Oncol. Biol. Phys. 33:1995;979-983.
4. Brewster L., Mohan R., Mageras G., et al. Three dimensional conformal treatment planning with multileaf collimators. Int. J. Radiat. Oncol. Biol. Phys. 33:1995;1081-1089.
5. Hayman J., Weeks J., Mauch P. Economic analyses in health care An introduction to the methodology with an emphasis on radiation therapy . Int. J. Rad. Oncol. Biol. Phys. 35:1996;827-841.
6. Konski A., Grigsby P. Economic analysis New endpoints for clinical trials . Int. J. Radiat. Oncol. Biol. Phys. 35:1996;827-841.
7. Dale R.G., Jones B. Radiobiologically based assessments of the net costs of fractionated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 36:1996;739-746.
8. Barendsen G.W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int. J. Radiat. Oncol. Biol. Phys. 8:1982;1981-1997.
9. Jones B., Tan L.T., Dale R.G. Derivation of the optimum dose per fraction from the linear quadratic model. Brit. J. Radiol. 68:1995;894-902.
10. Van der Kogel A.J. Radiobiology of normal tissues. Steel G.G. Basic clinical radiobiology. 1993;Edward Arnold, London.
11. Jones B., Dale R.G. The reduction in tumour control with increasing overall time Mathematical considerations . Brit. J. Radiol. 69:1996;830-838.
12. Withers H.R., Taylor J.M.G., Maciejewski B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta. Oncol. 27:1988;131-146.
13. Maciejewski B., Majewski S. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother. Oncol. 21:1991;163-170.
14. Amdur R., Parsons J., Fitzgerald L., et al. The effect of overall treatment time on local control in patients with adenocarcinoma of the prostate treated with radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 26:1990;1377-1382.
15. Kajanti M., Holsti L., Holsti P., et al. Effect of split course radiotherapy on survival and local control in advanced localised prostatic carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 26:1992;211-216.
16. Brierley J.D., Keane T.J., Cummings B., Hao Y. The absence of an adverse effect of prolongation of radiation treatment of primary rectal adenocarcinoma. Clin. Oncol. 8:1996;97-101.
17. Haustermans K.M.G., Hofland I., Van Poppel H., et al. Cell kinetic measurements in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;1067-1070.
18. Aherne W.A., Campeljohn R.S., Wright N.A. An introduction to cell population kinetics. 1976;Edward Arnold, London.
19. Ling C.C., Fuks Z. Conformal radiation treatment A critical appraisal . Eur. J. Cancer. 31:(A5):1995;799-803.
20. Hall E.J., Brenner D.J. The radiobiology of radiosurgery rationale for different treatment regimes for AVM's and Malignancies . Int. J. Radiat. Oncol. Biol. Phys. 25:1993;381-385.
21. Shrieve D.C., Loeffler J.S. Optimal fractionation schedules in small field radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 30:1994;497-499.
22. Jones B., Tan L.T., Freestone G., et al. Non-uniform dwell times in line source high dose rate brachytherapy Physical and radiobiological considerations . Brit. J. Radiol. 67:1994;1231-1237.
23. Niemierko A., Goitein M. Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture. Radiother. Oncol. 20:1991;166-176.
24. Roeska J.C., Mundt A.J., Halpern H., et al. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix A dosimetric analysis . Int. J. Radiat. Oncol. Biol. Phys. 37:1997;359-365.
25. Hendry J.H., Bentzen S.M., Dale R.G., et al. A modeled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin. Oncol. 8:1996;297-307.